|
Volumn 11, Issue 6, 1997, Pages 310-323
|
The clinical evaluation of agents for the prophylaxis and treatment of herpesvirus infections
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
ANTIVIRUS AGENT;
CORTICOSTEROID;
FAMCICLOVIR;
FOSCARNET;
GANCICLOVIR;
PLACEBO;
TRIFLURIDINE;
VALACICLOVIR;
VIDARABINE;
ARTICLE;
BONE MARROW TOXICITY;
CHICKENPOX;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONGENITAL INFECTION;
CYTOMEGALOVIRUS INFECTION;
DRUG SCREENING;
EPSTEIN BARR VIRUS;
GENITAL HERPES;
HERPES LABIALIS;
HERPES SIMPLEX ENCEPHALITIS;
HERPES SIMPLEX KERATITIS;
HERPES SIMPLEX VIRUS 1;
HERPES SIMPLEX VIRUS 2;
HERPES VIRUS;
HERPES ZOSTER;
HUMAN;
HUMAN CYTOMEGALOVIRUS;
INFECTION PREVENTION;
INFECTIOUS MONONUCLEOSIS;
INTRAOCULAR DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
INTRAVITREAL DRUG ADMINISTRATION;
LABORATORY DIAGNOSIS;
LIVER TOXICITY;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RETINITIS;
TOPICAL DRUG ADMINISTRATION;
VARICELLA ZOSTER VIRUS;
VIREMIA;
VIRUS INFECTION;
|
EID: 0031422095
PISSN: 13649027
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|